Cargando…
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial
IMPORTANCE: Findings suggest that the efficacy of D-cycloserine (DCS) for enhancing exposure therapy may be strongest when administered after sessions marked by low fear at the conclusion of exposure practice. These findings have prompted investigation of DCS dosing tailored to results of exposure s...
Autores principales: | Smits, Jasper A. J., Pollack, Mark H., Rosenfield, David, Otto, Michael W., Dowd, Sheila, Carpenter, Joseph, Dutcher, Christina D., Lewis, Elizabeth M., Witcraft, Sara M., Papini, Santiago, Curtiss, Joshua, Andrews, Leigh, Kind, Shelley, Conroy, Kristina, Hofmann, Stefan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273198/ https://www.ncbi.nlm.nih.gov/pubmed/32496566 http://dx.doi.org/10.1001/jamanetworkopen.2020.6777 |
Ejemplares similares
-
Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder
por: Hofmann, Stefan G., et al.
Publicado: (2019) -
D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders
por: Hofmann, Stefan G, et al.
Publicado: (2013) -
Approach bias retraining to augment smoking cessation: Study protocol for a randomized controlled trial()
por: Smits, Jasper A.J., et al.
Publicado: (2019) -
D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis
por: Bürkner, Paul-Christian, et al.
Publicado: (2017) -
Corrigendum to “Approach bias retraining to augment smoking cessation: Study protocol for a randomized controlled trial” [Contemp. Clin. Trials Commun. 14 (2019) 100340]
por: Smits, Jasper A.J., et al.
Publicado: (2022)